MARCKS and neoplasm: We found that MARCKS expression was elevated in tumor stroma and reduced in tumor epithelia as OC progresses (Figure 2C), and was increased in patients with a higher FIGO stage (Figure 2D) or in those that developed chemoresistance or disease recurrence (Figure 2E).